Read More Pharma Industry News What John M. Gay’s CFO appointment means for Pelthos Therapeutics (NYSE American: PTHS) and its next growth phase Pelthos Therapeutics has named John M. Gay as CFO. Read what the move signals for Zelsuvmi growth, funding strategy, and Pelthos stock now. byPallavi MadhirajuApril 11, 2026